Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00887536||Active, not recruiting||A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer||
||Other / Industry||
||3900||Female||18 Years to 70 Years (Adult, Older Adult)||NCT00887536||NSABP B-46-I
|May 2009||December 2017||January 2022||April 24, 2009||May 5, 2017||